Quantification of Nanomaterial/Nanomedicine Trafficking in Vivo.
Liming Wang,Liang Yan,Jing Liu,Chunying Chen,Yuliang Zhao
DOI: https://doi.org/10.1021/acs.analchem.7b04765
IF: 7.4
2017-01-01
Analytical Chemistry
Abstract:Absorption, distribution, metabolism and excretion (ADME) of nanomaterials (NMs) or nanomedicines (NMs), are fundamental biological processes that dominate their nanomedical functions or nanotoxicities. Mostly, NMs exist in biological systems as a form of nanoparticles (NPs). However, to determine the composition, spatial distribution, and states of existence of NMs/NPs in vivo, upon entry into the body, as well as to monitor the dynamic changes of these information over time remain a challenge for the current analytical methodology due to their limited efficiently in characterizing interactions between these complex(nano)-complex(bio) systems. NMs/NPs are more complicated compared with the classic chemical molecules, ions or elements, while biological systems pose even greater difficulties being a complicated network of chemical/biological composition, multihierarchical structures, the highly dynamic nature, nonequilibrium states and nonlinear chemical processes, etc. Thus, although some existing methods/protocols have promoted the understanding of how NMs/NPs interact with biological systems, almost none of these are fully adequate for quantitative analyses. Examples of conventional methods used for nano-bio analysis include, methods for element quantification which are partially applicable for NMs/NPs, such as atomic spectrometry, isotopic labelling and nuclear analytical methods, which are useful for elemental identification in determination of accumulation and distributions, and imaging-based methods have facilitated the quantification of NMs/NPs during their in vivo transportation, translocation and transformation processes. In the early stage of nanosafety research, qualitative study of NMs/NPs' behaviors in vivo was widely employed, which, however, have resulted in much inconsistency or even contradiction among reports on the same NMs/NPs' safety profile from different laboratories. Recently, it was recognized that quantitative analysis method are necessary for the accurate characterization of the complicated behaviors of NMs/NPs in vivo. For example, in order to understand the in vivo biological effects of a given nanomaterial, one needs to first monitor the dynamic changes of its components in blood circulation as well as in different organs or tissues to determine key bio-parameters such as the half-lives, and the composition of metabolites of the nanomaterial interested, etc. Such understanding requires quantitative methodology to construct a reliably whole spectrum of NMs/NPs' fate in vivo, which would be essential not only in nanosafety assessment of NMs/NPs, but also in the development of their biomedical applications in fields such as cancer nanotechnology.